1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsWells Fargo Trust Philanthropic Services Private Foundations is sponsored by Wells Fargo. Provides a range of information about private foundations that may offer grants in various program areas, including health and wellness.
Get alerted about grants like this
Save a search for “Wells Fargo” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Search for Private Foundations – Wells Fargo Philanthropic Services Esta página solo está disponible en inglés Selecione Cancele para permanecer en esta página o Continúe para ver nuestra página principal en español. Customer service and FAQs Find routing and account numbers How do I find my routing and account numbers? Is there a fee for Zelle ® ?
How do I report suspected fraud? Wells Fargo Trust Philanthropic Services Private Foundations As part of the Wealth & Investment Management division, Trust Philanthropic Services provides a full array of products and services through Wells Fargo Bank, N. A.
to private and family foundations across the country, including grant making support. For these foundations, Wells Fargo Bank serves as sole trustee, co-trustee or agent. To serve these foundations, we seek to help non-profit organizations identify appropriate grant resources for specific funding needs.
To help you find these grants, we provide a wide range of information about these foundations through our search feature.
Search by Program Area and State Search By Program Area and State Arts, Culture and Humanities International/Foreign Affairs Learn more about the various Search by Program Area and State Search by Program Area and State Search By Program Area and State Arts, Culture and Humanities International/Foreign Affairs Learn more about the various Frequently Asked Questions Grant Program or Technical Support Wells Fargo Trust Philanthropic Services Private Foundations The information on this page is a summary only and may not reflect all requirements related to a foundation’s grantmaking process.
In the event the information contained on this website differs from a foundation's governing instrument, the governing instrument shall control. Wealth & Investment Management offers financial products and services through affiliates of Wells Fargo & Company. Bank products and services are available through Wells Fargo Bank, N.
A. , Member FDIC. If you are an individual seeking a scholarship, please review scholarship opportunities at csascholars.
org . Wells Fargo Philanthropy and Community Impact For information regarding Wells Fargo’s social impact and philanthropy, please visit our Philanthropy and Community Impact page. Wells Fargo Bank, N.
A. Member FDIC. DT1-03202028-24-8066646-1.
2 You are leaving the Wells Fargo website. You are leaving wellsfargo. com and entering a website that Wells Fargo does not control.
According to the current listing, eligibility includes: Non-profit organizations seeking funding in health-related areas. Confirm the full requirements in the official notice before applying.
Wells Fargo Trust Philanthropic Services Private Foundations is funded by Wells Fargo. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
-Purpose. This Funding Opportunity Announcement (FOA) encourages Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) that propose to develop, standardize, and validate new and innovative assays, integrated strategies, or batteries of assays that determine or predict specific organ toxicities (e.g., ocular, dermal, hematotoxicity, cardiotoxicity, gastrointestinal toxicity, hepatotoxicity, nephrotoxicity, ototoxicity, olfactory loss, bladder toxicity, neurotoxicity, pulmonary toxicity, endocrine toxicity, and pancreatic beta cell toxicity), resulting from both acute and chronic exposures to various chemicals, environmental pollutants, biologics and therapeutic molecules or drugs. In addition, this FOA encourages the development, standardization, and validation of new models of arthritis, convulsion, infection and shock. New approaches for high throughput toxicity screening that involves the use of molecular endpoints, computer modeling, proteomics, genomics and epigenomics and the development of virtual tissues are also encouraged as are development of 3-dimensional organ models for toxicity evaluation. -Mechanism of Support. This FOA will utilize the SBIR (R43/R44) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-09-007, which encourages applications under the Small Business Technology Transfer (STTR) (R41/R42) grant mechanisms. Funding Opportunity Number: PA-09-006. Assistance Listing: 93.113,93.173,93.361,93.389,93.837,93.846,93.847,93.848,93.849,93.859,93.867. Funding Instrument: G. Category: ED,ENV,FN,HL.
Purpose. This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), National Institutes of Health (NIH), invites Small Business Innovation Research (SBIR) cooperative agreement applications from small business concerns (SBCs) that propose to develop new, or to improve existing application(s) of nanotechnology-based therapeutics or/and in vivo diagnostics. This FOA will specifically support pre-clinical optimization and testing of these cancer-relevant nanotechnology applications against the intended cancer type. The proposed projects must be milestone-driven and must be clearly directed toward development of an ultimate commercial product. The outcomes are expected to advance the discovery and pre-clinical optimization phase so that an Investigational New Drug (IND) or Investigational Device Exemptions (IDE) application could be submitted to the Food and Drug Administration (FDA) by the end or shortly after completion of the Phase II project period. To facilitate these steps, the NCI will assist the awardees in various ways, including the support through the NCI-sponsored Nanotechnology Characterization Laboratory. This FOA will NOT support basic research projects, studies on disease mechanisms, and clinical trials. Mechanism of Support. This FOA will utilize the SBIR (U43/U44) cooperative agreement mechanisms for Phase I and Phase II applications. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Funding Opportunity Number: PAR-10-286. Assistance Listing: 93.393,93.394,93.395,93.396. Funding Instrument: CA. Category: ED,HL. Award Amount: Up to $150K per award.
This Funding Opportunity Announcement (FOA) invites Small Business Innovation Research (SBIR) grant applications from small business concerns (SBCs) for funding to perform research leading to the development of innovative technologies that may advance progress for early detection and assessment of individuals at risk and for early diagnosis, prognosis and follow-up of type 1 diabetes (T1D). Funding Opportunity Number: RFA-DK-15-024. Assistance Listing: 93.847. Funding Instrument: G. Category: FN,HL. Award Amount: $2M total program funding.